NCT02695953
Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy
Enrolling by Invitation
Not specifiedAges 18–55ObservationalMilissa KaufmanInvestigator-initiated
~130 participants
Updated 2026-06-25 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Potential Change in Evidence of PTSD symptoms with neuroimaging
Measured over Within 30 days before and again within 30 days after Cognitive Processing Therapy Treatment.
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Milissa L Kaufman, MD/PhD · PRINCIPAL_INVESTIGATOR · Mclean Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
PTSD diagnosis, as measured by the Clinician Administered PTSD Scale for DSM-5
history of chronic childhood trauma due to relational abuse
Ability to understand and sign informed consent
Enrollment in CPT program at McLean Hospital
Both genders, all ethnic backgrounds, age between 18 and 55
Fluent English speakers
Normal or Corrected Vision
Exclusion
History or current schizophrenia spectrum disorder or other psychotic disorders
History or current bipolar or other related disorders
Alcohol and/or substance use disorder within the past month
Metal implants
Medical or neurological illness (e.g., seizures, head injury in which they experienced a loss of consciousness)
Positive pregnancy test
What this trial measures
- Potential Change in Evidence of PTSD symptoms with neuroimagingWithin 30 days before and again within 30 days after Cognitive Processing Therapy Treatment.